Answers are grounded in this paper and cite their sources.
Within the last year, the intensive development of π-conjugated small molecule acceptors has yielded viable alternatives to fullerene acceptors in state-of-the-art organic photovoltaic devices.
No takes yet. Share an insight, caveat, or question.
McAfee et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: